The top 5 vaccines by 2020
June 26, 2014
Pfizer's ($PFE) Prevnar 13 currently dominates the list of the world's best-selling vaccines--and that won't be changing anytime soon, according to a new report from EvaluatePharma. In fact, it's expected to widen its lead, with sales growing more than 61% over the next 5+ years; by 2020, it will be generating nearly $4 billion more than runner up Pentacel from Sanofi ($SNY), EP predicts.
Check out the projections for the top 5 best-selling vaccines by 2020, and see how they stack up to those on the 2013 list.
Sign up for FierceVaccines's free email newsletter to see how the 2020 forecast stacks up.
Current Subscribers: Please fill this form out once, and you won't see it again.
If you're having difficulty with this form, please email firstname.lastname@example.org for assistance.